Matthew Mcpherron V serves as Executive at MAP Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Matthew Mcpherron V has executed 4 insider transactions totaling $7.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 1, 2013 involved transacting 2,999,526 shares valued at $75.0M.
Matthew Mcpherron V currently holds 2,885,364 shares of MAP Pharmaceuticals, Inc. (MAPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Mcpherron V has been a net buyer of MAPP stock. They have purchased $7.2M and sold $0 worth of shares.
Matthew Mcpherron V's most recent insider trade was on Mar 1, 2013, when they sold 2,999,526 shares at $25.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 11, 2007 | MAPP | $1.7M | Other | 114,162 | $14.50 | Discretionary |
| Oct 5, 2007 | MAPP | $7.2M | Purchase | 600,000 | $12.00 | Discretionary |